{"id":"NCT00319696","sponsor":"Actelion","briefTitle":"Bosentan in Digital Ulcers","officialTitle":"Long-term Bosentan Open Label Extension of the AC-052-331 Study in Systemic Sclerosis Patients With Ischemic Digital Ulcers","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-07-08","primaryCompletion":"2009-01-22","completion":"2009-01-22","firstPosted":"2006-04-27","resultsPosted":"2012-08-08","lastUpdate":"2025-02-04"},"enrollment":116,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Digital Ulcers"],"interventions":[{"type":"DRUG","name":"Bosentan 62.5 mg","otherNames":[]},{"type":"DRUG","name":"Bosentan 125 mg","otherNames":[]}],"arms":[{"label":"Bosentan","type":"EXPERIMENTAL"}],"summary":"The aim of the study is to collect long-term efficacy, tolerability and safety data of bosentan in Systemic Sclerosis (SSc) patients suffering from ischemic digital ulcers (DUs).","primaryOutcome":{"measure":"Time to Complete Healing of Each Baseline DU","timeFrame":"Baseline to healing","effectByArm":[],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":45,"n":116},"commonTop":["SKIN ULCER","UPPER RESPIRATORY TRACT INFECTION","ARTHRALGIA","DIARRHOEA","INFECTED SKIN ULCER"]}}